UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 26, 2008
ADVANCED MEDICAL OPTICS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 01-31257 | 33-0986820 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 1700 E. St. Andrew Place Santa Ana, CA |
92705 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (714) 247-8200
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
EXPLANATORY NOTE
On April 2, 2007, Advanced Medical Optics, Inc. (the “Company”), a Delaware corporation, completed the acquisition of all the outstanding voting securities of IntraLase Corp.
The Company is filing this Current Report on Form 8-K in connection with the filing of the Company’s registration statement on Form S-3 on August 26, 2008 to include unaudited pro forma condensed combined financial information reflecting the acquisition of IntraLase Corp., as updated through December 31, 2007.
| Item 9.01 | Financial Statements and Exhibits |
| (b) | Pro Forma Financial Information |
The unaudited pro forma condensed combined statement of operations reflecting the acquisition of IntraLase Corp. through December 31, 2007 are attached hereto as Exhibit 99.1.
| (d) | Exhibits |
| 99.1 | Unaudited pro forma condensed combined statement of operations described in 9.01(b). | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ADVANCED MEDICAL OPTICS, INC. | ||||||||
| (Registrant) | ||||||||
| Date: August 25, 2008 | By: | /s/ MICHAEL J. LAMBERT | ||||||
| Michael J. Lambert, | ||||||||
| Executive Vice President and | ||||||||
| Chief Financial Officer | ||||||||
EXHIBIT INDEX
| Exhibit |
||
| 99.1 | Unaudited pro forma condensed combined statement of operations described in Item 9.01(b) | |